Atlas Trials

Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination

Clinical trial NCT01432301 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT01432301
Sponsor
Wellstat Therapeutics
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Toxicity Due to Chemotherapy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.